# Withings: A Connected Health Pioneer
Withings is a French consumer electronics company that designs and manufactures clinically validated smart health devices for home-based health monitoring.[1][2] Founded in 2008, the company creates a comprehensive ecosystem of connected devices—including smart scales, blood pressure monitors, hybrid smartwatches, and sleep analyzers—that enable users to track vital health metrics with medical-grade accuracy.[2] Withings serves millions of users worldwide who seek preventative health solutions and long-term health insights through daily measurement and monitoring.[1][2] The company's core mission centers on democratizing clinical-grade health measurement, allowing people to take medical-grade measurements at home and gain actionable insights through its companion app and health programs.[2]
The company operates at the intersection of consumer electronics and digital health, positioning itself as a leader in the connected health space. With approximately 400 employees and headquarters in Issy-les-Moulineaux, France, Withings has achieved $100.3 million in revenue and secured $93.8 million in total funding across three rounds.[3]
Withings was founded on June 19, 2008, by Éric Carreel, Cédric Hutchings, and Fred Potter, three engineers with complementary expertise in telecommunications, product development, and user experience.[1] Carreel, a telecommunications engineer, brought deep technology and innovation expertise, while Hutchings contributed engineering and business acumen, and Potter provided product development and user experience knowledge.[1] This combination of technical talent and business sensibility positioned the company to pioneer a new category.
The company's breakthrough moment came in 2009 with the launch of the world's first Wi-Fi connected scale, which revolutionized personal health tracking by enabling remote monitoring and data synchronization.[1] This innovation established Withings as a category creator. The company subsequently expanded its product line with the first connected blood pressure monitor in 2011 and the Aura sleep tracking mat in 2014, demonstrating consistent innovation across multiple health domains.[1] A significant inflection point occurred when Nokia acquired Withings in April 2016, followed by Éric Carreel's repurchase of the company in May 2018—a move that underscored the founder's commitment to the company's independent vision.[1]
Withings operates within the preventative health and digital wellness megatrend, where consumers increasingly seek to monitor and manage their health proactively rather than reactively.[1][2] The timing is particularly favorable: aging populations in developed markets, rising healthcare costs, and growing consumer interest in personalized health data create strong tailwinds for connected health solutions.
The company influences the broader ecosystem by establishing standards for what "clinical-grade" means in consumer health devices, effectively raising the bar for competitors and legitimizing home-based health monitoring as a clinical tool rather than a fitness gimmick. By pioneering categories like connected scales and blood pressure monitors, Withings has shaped consumer expectations and regulatory frameworks around connected health devices.
Withings is well-positioned to capitalize on the convergence of wearable technology, preventative healthcare, and data-driven wellness. The company's recent announcement at CES 2025 of OMNIA—a conceptual product providing a 360-degree view of vital indicators—alongside innovations like BPM Vision and Cardio Check-Up, signals continued investment in comprehensive health monitoring platforms.[3]
The key question for Withings' evolution is whether it can transition from a device manufacturer to a health intelligence platform. As healthcare systems increasingly adopt remote patient monitoring and preventative care models, Withings' clinical credibility and existing user base position it to become infrastructure for digital health ecosystems. The company's ability to partner with healthcare providers and insurers—rather than remaining purely consumer-focused—will likely determine its long-term influence and valuation trajectory in an increasingly competitive connected health market.
Withings has raised $90.0M in total across 2 funding rounds.
Withings's investors include IDInvest Partners.
Withings has raised $90.0M across 2 funding rounds. Most recently, it raised $60.0M Series B in July 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 1, 2020 | $60.0M Series B | IDInvest Partners | |
| Jul 1, 2013 | $30.0M Series B | IDInvest Partners |
